Abstract
In patients with troponin-negative acute coronary syndromes, creatine kinase (CK)-MB elevation predicts a significantly higher risk of death and major acute cardiac events compared with CK-MB negative patients. This risk is accentuated in troponin-negative, CK-MB positive patients who do not demonstrate ST elevation by electrocardiogram.
MeSH terms
-
Acute Disease
-
Aged
-
Biomarkers / blood
-
Coronary Disease / blood*
-
Coronary Disease / complications
-
Coronary Disease / mortality
-
Creatine Kinase / blood*
-
Female
-
Heart Failure / complications
-
Humans
-
Isoenzymes / blood*
-
Logistic Models
-
Male
-
Middle Aged
-
Multivariate Analysis
-
Patient Readmission / statistics & numerical data
-
Predictive Value of Tests
-
Prognosis
-
Syndrome
-
Troponin I / blood*
Substances
-
Biomarkers
-
Isoenzymes
-
Troponin I
-
Creatine Kinase